<html>
<head>
<title>Circulatory and Hematologic Systems</title>
</head>
<body>
  <h1><center>Circulatory and Hematologic Systems</center></h1></title>
<br>
  <b>Cardiovascular Chest Pain</b>
<Br>
  A patient tells you he has paroxysmic atrial fibrillation. Which symptoms would you expect him to report?
<form>
  <input type="radio" id="A" name="1" value="A">
  <label for="male"> A. Occasionally, symptoms appear to come and go and not last more than an hour. </label><br>
  <input type="radio" id="B" name="1" value="B">
  <label for="female"> B. He seems to have symptoms constantly and this is the reason that he came back to the doctor.</label><br>
  <input type="radio" id="C" name="1" value="C">
  <label for="other"> C. He is currently in treatment for atrial fibrillation and it is under control.</label><br>
  <input type="radio" id="D" name="1" value="D">
  <label for="other"> D. None of the above.</label><br>
</form> 
Answer: <p style="color:white">A - In medicine, when a condition is noted as paroxysmal, it means that the condition is not constant and that it occurs occasionally with symptoms that come and go and tend to not last that long. The symptoms and condition may resolve themselves without medical intervention. Medical intervention can shorten the symptoms and/or decrease the amount of times the symptoms occur.</p>
  <br>
  When a patient has inadequate blood supply to the heart, what is the resulting chest pain called?
  <form>
  <input type="radio" id="A" name="1" value="A">
  <label for="male"> A. CVA </label><br>
  <input type="radio" id="B" name="1" value="B">
  <label for="female"> B. TIA </label><br>
  <input type="radio" id="C" name="1" value="C">
  <label for="other"> C. Angina</label><br>
  <input type="radio" id="D" name="1" value="D">
  <label for="other"> D. IVC</label><br>
</form> 
Answer: <p style="color:white"> Angina is the chest pain resulting from insufficient blood supply to the heart and is treated by vasodilators such as nitroglycerin.</p>
  <br>
  <b>Palpitations/Rhythm Disturbances</b>
<br>
  <b>Edema and Swelling</b>
<Br>
  <b>Masses and Lymphadenopathy</b>
<br>
  <b>Extremity Pain and Claudication</b>
<br>
  <b>Shortness of Breath/Dyspnea and Orthopnea</b>
<br>
  <b>Bruising, Bleeding, and Clotting Disturbances</b>
<br>
  <b>Circulatory Collapse and Shock</b>
<br>
  <b>Blood Pressure Evaluation</b>
<br>
  <b>Chest Trauma</b>
<br>
  <b>Physical Exam Findings Related to the Circulatory and Hematologic Systems</b>
<br>
<b>Laboratory Test Findings and Diagnostic Imaging Related to the Circulatory and Hematologic Systems</b>
<br>
  Which of the following segments of an EKG can remain abnormal weeks to months after an acute myocardial infarction?
  <br>
 <form>
  <input type="radio" id="A" name="1" value="A">
  <label for="male"> A. Q </label><br>
  <input type="radio" id="B" name="1" value="B">
  <label for="female"> B. P</label><br>
  <input type="radio" id="C" name="1" value="C">
  <label for="other"> C. T</label><br>
  <input type="radio" id="D" name="1" value="D">
  <label for="other"> D. ST</label><br>
</form> 
Answer: <p style="color:white">A - In an acute myocardial infarction, the EKG changes over time. The initial changes are shown in ST segment elevation, which decreases over time to appear normal again. Weeks to months after an acute myocardial infarction, the Q wave can stay decreased. In the same time frame, the P and T waves tend to go back to an almost near normal quality.<br>
<br> 
<br>
  <h1><center>Blood and Lymphoreticular System</center></h1>
  <br>
  <h2>Normal Processes</h2><br>
  <b>Embryonic development, fetal maturation, and perinatal changes</b>
  <br>
  <b>Organ structure and function</b>
  <br>
  <b>Cell/tissue structure and function</b>
  <br>
<i>Production and function of erythrocytes, including heme and hemoglobin synthesis; hemoglobin O2 and CO2 transport, transport proteins, erythropoietin</i><br>
  <i>Production and function of platelets</i><br>
  <i>Production and function of coagulation and fibrinolytic factors; hemostasis</i><br>
  <b>Repair, regeneration, and changes associated with stage of life</b><br>
<h2>Abnormal Processes: Health and Health Maintenance, Screening, Diagnosis, Management, Risks, Prognosis</h2><br>
  <h3>Infectious and immunologic</h3><br>
  <b>Infectious disorders</b><br>
  <i>Bacteria</i><br>
<i>Viral: hemorrhagic fever (Ebola virus, Marburg virus); chikungunya; dengue fever; Zika virus disease</i><br>
  <i>Parasitic: malaria (Plasmodium spp); babesiosis (Babesia species)</i><br>
<i>Primary infections of lymphoid tissue: lymphadenitis (viral, bacterial, fungal, parasitic); lymphangitis; buboes, bubonic plague (Yersinia pestis); cat scratch disease (Bartonella henselae)</i><br>
  <b>Immunologic and inflammatory disorders</b><br>
  <i>Cryoglobinemia, essential mixed cryoglobinemia; autoimmune hemolytic anemia; paroxysmal nocturnal hemoglobinuria; thrombotic thrombocytopenic purpura; hemolytic uremic syndrome </i><br>
  <b>Neoplasms</b><br>
  <i>leukemia, acute (ALL, AML); leukemia, chronic (CLL, CML); lymphomas, Hodgkin disease, non-Hodgkin lymphoma, Burkitt lymphoma, T-cell lymphoma; multiple myeloma, dysproteinemias, monoclonal gammopathy of unknown significance (MGUS); myelofibrosis; myelodysplastic syndrome, myelodysplasias; other immunoproliferative neoplasms (eg, Waldenstrom macroglobulinemia) </i><br>
  <b>Anemia, cytopenias, and polycythemia anemias</b><br>
  <i>Decreased production: anemia of chronic disease</i><br>
  <i>Hemolysis: glucose-6-phosphate dehydrogenase deficiency; pyruvate kinase deficiency</i><br>
<i>Disorders of hemoglobin, heme, or membrane: disorders of red cell membranes; hereditary spherocytosis, elliptocytosis; methemoglobinemia, congenital; sickle cell disease; sideroblastic anemia; thalassemias </i><br>
  <i>Other causes of anemia: blood loss, acute and chronic as a cause of anemia</i><br>
<i>Cytopenias: aplastic anemia; leukopenia; neutropenia, cyclic neutropenia, agranulocytosis; pancytopenia; thrombocytopenia, quantitative; immune thrombocytopenic purpura (ITP)</i><br>
  <i>Cythemias: leukocytosis; polycythemia vera; secondary polycythemia</i><br>
  <b>Coagulation disorders (hypocoagulable and hypercoagulable conditions)</b><br>
<i>Hypocoagulable: disseminated intravascular coagulation; hemophilia, congenital factor VIII [hemophilia A] and IX [hemophilia B]; hypofibrinogenemia; von Willebrand disease; platelet dysfunction, qualitative </i><br>
<i>Hypercoagulable: heparin-induced thrombocytopenia; other coagulopathies (eg, homocysteinemia, hypoplasminogenemia, antithrombin III, protein C/protein S deficiency, Factor V Leiden, anticardiolipin antibodies, lupus anticoagulant, prothrombin G20210A mutation) </i><br>
<i>Reactions to blood components: ABO incompatibility/anaphylaxis; Rh incompatibility/anaphylaxis; hemolysis, delayed; transfusion reaction; transfusion contaminated with bacteria; transfusion-related acute lung injury (TRALI); anaphylactoid reaction (IgA deficiency)</i><br>
  <b>Traumatic, mechanical, and vascular disorders</b><br>
  <i>Mechanical injury to erythrocytes (eg, cardiac valve hemolysis)</i><br>
<i>Disorders of the spleen; splenic rupture/laceration; splenic infarct; splenic abscess; effects/complications of splenectomy (eg, sepsis due to encapsulated bacteria); hypersplenism </i><br>
  <b>Adverse effects of drugs on the hematologic and lymphoreticular systems</b></br>
  <i>Antiplatelet drugs, antithrombin drugs (eg, dabigatran); chemotherapeutic agents; inhibitors of coagulation factors; methemoglobinemia, acquired; propylthiouracil; tumor lysis syndrome; warfarin </i><br>
  <h2>Normal Processes</h2><br>
  <b>Embryonic development, fetal maturation, and perinatal transitional changes</b><br>
  <b>Organ structure and function</b><br>
<i>Chambers, valves</i><br>
  <i>Cardiac cycle, mechanics, heart sounds, cardiac conduction</i><br>
  <i>Hemodynamics, including blood volume and systemic vascular resistance</i><br>
  <b>Circulation in specific vascular beds, including pulmonary and coronary</b><br>
  <b>Cell/tissue structure and function</b><br>
<i>Heart muscle, metabolism, oxygen consumption, biochemistry, and secretory function (eg, atrial natriuretic peptide)</i><br>
  <i>Endothelium and secretory function, vascular smooth muscle, microcirculation, and lymph flow</i><br>
<i>Neural and hormonal regulation of the heart, blood vessels, and blood volume, including responses to change in posture, exercise, and tissue metabolism, and autonomic responses</i><br>
  <b>Repair, regeneration, and changes associated with stage of life</b><br>
<h2>Abnormal Processes: Health and Health Maintenance, Screening, Diagnosis, Management, Risks, Prognosis</h2><br>
  <h3>Infectious, immunologic, and inflammatory disorders</h3><br>
  <b>infectious disorders</b><br>
  <i>bacterial endocarditis, myocarditis</i><br>
  <b>immunologic and inflammatory disorders</b><br>
  <i>atherosclerosis (eg, atherosclerosis of the aorta)</i><br>
  <b>Neoplasms: myxoma, metastases</b><br>
  <b>Dysrhythmias</b><br>
  <i>premature beats (PACs, PVCs); atrial flutter/fibrillation; multifocal atrial tachycardia; paroxysmal tachycardias; ventricular tachycardia/fibrillation; wide complex tachycardia; torsades de pointes; bradycardias; atrioventricular block (first-, second-, third-degree); conduction disorder (LBBB, RBBB); cardiac arrest; sick sinus syndrome; prolonged QT syndrome; Wolff-Parkinson-White syndrome; carotid sinus hypersensitivity, pacemaker dysfunction, including failure to sense, capture</i><br>
  <b>Heart failure</b><br>
  <i>chordae tendineae rupture; congestive heart failure; cor pulmonale; diastolic dysfunction; systolic dysfunction; mitral valve dysfunction; heart failure secondary to myocardial infarction; high-output heart failure, including thyrotoxicosis-induced, anemia-induced; tachycardia-induced; cardiogenic pulmonary edema</i><br>
  <b>Ischemic heart disease</b><br>
  <i>acute coronary syndrome, acute myocardial infarction; angina pectoris, stable and unstable/coronary artery disease/coronary insufficiency; coronary artery spasm</i>
  <b>Diseases of the myocardium</b><br>
  <i>cardiomyopathy, dilated, including alcoholic, viral, takotsubo; cardiomyopathy, obstructive hypertrophic; cardiomyopathy, familial dilated; cardiomyopathy, restrictive; hypertensive heart disease, left ventricular hypertrophy, right ventricular hypertrophy; complications of myocardial infarction; nontraumatic tamponade post-myocardial infarction; papillary muscle rupture/dysfunction; ventricular free wall rupture; myocarditis</i><br>
  <b>Diseases of the pericardium</b><br>
  <i>chronic constrictive pericarditis; pericardial effusion; pericardial tamponade; acute pericarditis; pericarditis, following myocardial infarction, surgery, trauma</i><br>
  <b>Valvular heart disease</b><br>
  <i>valve disorders, mitral/aortic/tricuspid, pulmonic (eg, regurgitation, stenosis, prolapse, insufficiency, vegetation); functional murmurs; rheumatic heart disease; complications of artificial valves</i><br>
  <b>Hypotension: orthostatic hypotension</b><br>
  <b>Hypertension</b><br>
  <i>elevated blood pressure reading without diagnosis of hypertension; essential hypertension; malignant hypertension; secondary hypertension</i><br>
  <b>Dyslipidemia</b><br> 
  <i>hypercholesterolemia; hyperlipidemia; hypertriglyceridemia; lipoproteins/lipoprotein lipase deficiency</i><br>
  <b>Vascular disorders</b>
<i>disorders of the great vessels: aneurysm, aortic (abdominal/thoracic), dissection, ruptured; aneurysm, iliac, other peripheral vascular, ruptured; aortoiliac disease; peripheral arterial vascular disease: arterial embolus/thrombosis; arteriovenous fistula; atheroembolic disease; claudication; cholesterol emboli; hypertensive vascular disease; peripheral arterial disease; thromboangiitis obliterans diseases of the veins: deep venous thrombosis, venous thromboembolism; phlebitis/thrombophlebitis; varicose veins; venous insufficiency; stasis ulcers, stasis dermatitis</i><br>
  <b>Traumatic and mechanical disorders</b><br>
  <i>ventricular puncture; myocardial contusion; myocardial rupture; traumatic aortic dissection; traumatic tamponade</i><br>
  <b>Congenital disorders, including disease in adults</b><br>
  <i>anomalous left coronary artery; atrial septal defect; coarctation of the aorta; endocardial cushion defect; patent foramen ovale; patent ductus arteriosus; tetralogy of Fallot; transposition of the great vessels; ventricular septal defect</i><br>
  <b>Adverse effects of drugs on the cardiovascular system</b><br>
  <i>adriamycin; cocaine, amphetamine, PCP; ACE inhibitors, calcium channel blockers, alpha blockers, minoxidil</i><br>
  
  </body>
</html>
